131 related articles for article (PubMed ID: 28544636)
1. Visit-to-visit systolic blood pressure variability predicts treatment-related adverse event of hyponatremia in SPRINT.
Goyal A; Mezue K; Rangaswami J
Cardiovasc Ther; 2017 Aug; 35(4):. PubMed ID: 28544636
[TBL] [Abstract][Full Text] [Related]
2. Blood Pressure Variability Predicts Adverse Events and Cardiovascular Outcomes in Chronic Kidney Disease: A Post-Hoc Analysis of the SPRINT Trial.
Mezue K; Goyal A; Pressman GS; Horrow JC; Rangaswami J
Am J Hypertens; 2017 Dec; 31(1):48-52. PubMed ID: 28985328
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure variability predicts adverse events and cardiovascular outcomes in SPRINT.
Mezue K; Goyal A; Pressman GS; Matthew R; Horrow JC; Rangaswami J
J Clin Hypertens (Greenwich); 2018 Sep; 20(9):1247-1252. PubMed ID: 29984884
[TBL] [Abstract][Full Text] [Related]
4. Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results.
Huang C; Dhruva SS; Coppi AC; Warner F; Li SX; Lin H; Nasir K; Krumholz HM
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29133522
[TBL] [Abstract][Full Text] [Related]
5. Elevated High-Density Lipoprotein Cholesterol Is Associated with Hyponatremia in Hypertensive Patients.
Israel A; Grossman E
Am J Med; 2017 Nov; 130(11):1324.e7-1324.e13. PubMed ID: 28623175
[TBL] [Abstract][Full Text] [Related]
6. Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease.
Mallamaci F; Minutolo R; Leonardis D; D'Arrigo G; Tripepi G; Rapisarda F; Cicchetti T; Maimone I; Enia G; Postorino M; Santoro D; Fuiano G; De Nicola L; Conte G; Zoccali C
Kidney Int; 2013 Aug; 84(2):381-9. PubMed ID: 23615498
[TBL] [Abstract][Full Text] [Related]
7. Longterm blood pressure variability in patients with rheumatoid arthritis and its effect on cardiovascular events and all-cause mortality in RA: a population-based comparative cohort study.
Myasoedova E; Crowson CS; Green AB; Matteson EL; Gabriel SE
J Rheumatol; 2014 Aug; 41(8):1638-44. PubMed ID: 24986852
[TBL] [Abstract][Full Text] [Related]
8. SPRINT trial: It's not just the blood pressure!
Berkelmans GF; Visseren FL; Jaspers NE; Spiering W; van der Graaf Y; Dorresteijn JA
Eur J Prev Cardiol; 2017 Sep; 24(14):1482-1484. PubMed ID: 28749177
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Risk in Hypertension in Relation to Achieved Blood Pressure Using Automated Office Blood Pressure Measurement.
Myers MG; Kaczorowski J; Dolovich L; Tu K; Paterson JM
Hypertension; 2016 Oct; 68(4):866-72. PubMed ID: 27528062
[TBL] [Abstract][Full Text] [Related]
10. [The SPRINT Research. A Randomized Trial of Intensive versus Standard Blood-Pressure Control].
Widimský J
Vnitr Lek; 2016 Jan; 62(1):44-7. PubMed ID: 26967236
[TBL] [Abstract][Full Text] [Related]
11. Low Diastolic Blood Pressure is Not Related to Risk of First Episode of Stroke in a High-Risk Population: A Secondary Analysis of SPRINT.
Sobieraj P; Lewandowski J; Siński M; Symonides B; Gaciong Z
J Am Heart Assoc; 2019 Feb; 8(4):e010811. PubMed ID: 30744452
[TBL] [Abstract][Full Text] [Related]
12. Intensive Blood Pressure Treatment for Resistant Hypertension.
Tsujimoto T; Kajio H
Hypertension; 2019 Feb; 73(2):415-423. PubMed ID: 30580680
[TBL] [Abstract][Full Text] [Related]
13. Impact of visit-to-visit variability and systolic blood pressure control on subsequent outcomes in hypertensive patients with coronary artery disease (from the HIJ-CREATE substudy).
Arashi H; Ogawa H; Yamaguchi J; Kawada-Watanabe E; Hagiwara N
Am J Cardiol; 2015 Jul; 116(2):236-42. PubMed ID: 25966826
[TBL] [Abstract][Full Text] [Related]
14. Personalizing the Intensity of Blood Pressure Control: Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial).
Patel KK; Arnold SV; Chan PS; Tang Y; Pokharel Y; Jones PG; Spertus JA
Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28373269
[TBL] [Abstract][Full Text] [Related]
15. Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk.
Böhm M; Schumacher H; Leong D; Mancia G; Unger T; Schmieder R; Custodis F; Diener HC; Laufs U; Lonn E; Sliwa K; Teo K; Fagard R; Redon J; Sleight P; Anderson C; O'Donnell M; Yusuf S
Hypertension; 2015 Mar; 65(3):651-61. PubMed ID: 25583157
[TBL] [Abstract][Full Text] [Related]
16. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994.
Muntner P; Shimbo D; Tonelli M; Reynolds K; Arnett DK; Oparil S
Hypertension; 2011 Feb; 57(2):160-6. PubMed ID: 21200000
[TBL] [Abstract][Full Text] [Related]
17. Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.
Brouwer TF; Vehmeijer JT; Kalkman DN; Berger WR; van den Born BH; Peters RJ; Knops RE
Diabetes Care; 2018 Jun; 41(6):1142-1148. PubMed ID: 29212825
[TBL] [Abstract][Full Text] [Related]
18. Implications of Blood Pressure Measurement Technique for Implementation of Systolic Blood Pressure Intervention Trial (SPRINT).
Agarwal R
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28159816
[TBL] [Abstract][Full Text] [Related]
19. Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation: The AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management).
Proietti M; Romiti GF; Olshansky B; Lip GYH
Hypertension; 2017 Nov; 70(5):949-958. PubMed ID: 28974568
[TBL] [Abstract][Full Text] [Related]
20. Systolic Blood Pressure Time in Target Range and Cardiovascular Outcomes in Patients With Hypertension.
Fatani N; Dixon DL; Van Tassell BW; Fanikos J; Buckley LF
J Am Coll Cardiol; 2021 Mar; 77(10):1290-1299. PubMed ID: 33706870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
